Drug Availability Notices


The TMS Team will do its best to let the community know about Drug Recalls and Shortages that will most affect our community! If you know of something that is current and should be on the list, email us at info@tmsforacure.org and our team will investigate it.


Drug Recall Notices


Budesonide Extended-Release Tablets 9mg, 30-count bottle– Teva Pharmaceuticals USA has initiated a recall of Budesonide Extended-Release Tablets 9mg, 30-count bottle, manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA.  Please look for Lot # 100047273; Exp. 07/2025.  Budesonide is used as an anti-inflammatory drug and for other off-label uses. 



Drug Shortages

If one of your medications is experiencing a shortage, check out our helpful Shortage Guide and connect your physician for help. We will specify if this is a partial shortage announced by the company or an FDA shortage listed on the FDA’s website.

If you think a medication that you take is experiencing a shortage, the FDA launched a new portal for patients, consumers and health care professionals to report potential drug shortage issues directly into CDER’s NextGen system without creating a NextGen account!


Midostaurin Capsules- This was posted in the University of Utah’s Drug Shortage Bulletin on 12/13/2023. Rydapt 25 mg has been placed on backorder and it is unknown when it will be available to order again.


Cromolyn Sodium Concentrate – On FDA Shortage list as of 11/03/2023. See FDA information here.



Skip to content